Public Safety & Risk Management Approaches
Integrating risk factors, static vs dynamic risk assessment, desistance perspectives, and ineffective reoffending reduction methods analyzed by Dr. Jo Bailey on December 8, 2020.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
IMPLEMENTATION GAP: HOW LONG HAVE WE KNOWN THAT INTERVENTIONS WORK Simon Gilbody Professor of Psychological Medicine & Psychiatric Epidemiology University of York January 2023
What works for people with SMI? Chipping away at this question for 15+ years
behavioural support + meds = double chances of quitting Clinical trials Evidence syntheses A large pragmatic trial for ppl with SMI
Level 1 evidence, based on systematic reviews, on the effectiveness of: NRT Bupropion Varenicline (when it becomes available) Behavioural support, following NCSCT & SCIMITAR model
Cumulative meta-analysis Q: When should we have known this? Q: How does this new trial change the story? Useful for policy analysis
When should we have known this? Cumulative meta-analysis of 25 trials & linkage to key policy initiatives
NRT Bupropion Varenicline (when it becomes available) Behavioural support, following NCSCT & SCIMITAR model
Disclaimer The SCIMITAR trial was funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (project number 07/41/05). The views and opinions expressed by authors do not necessarily reflect those of the National Health Service, NIHR, the NIHR Evaluation, Trials and Studies Coordinating entre, the HTA Programme, or the Department of Health.
